This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Washington University. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Michelle A Hurchla Pyles: Innovator in Lymphocyte Modulation
Introduction
Michelle A Hurchla Pyles is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of immunology, particularly in the modulation of lymphocyte activity. With a total of 2 patents, her work has implications for therapeutic, diagnostic, and research purposes.
Latest Patents
Her latest patents include compositions and methods for modulating lymphocyte activity. The present invention provides a novel lymphocyte inhibitory receptor termed BTLA, which is expressed on both T and B cells. It identifies HVEM as interacting with BTLA. Additionally, methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM are also provided.
Career Highlights
Michelle is affiliated with Washington University, where she continues her research and innovation in the field. Her work has garnered attention for its potential applications in medical science.
Collaborations
Some of her notable coworkers include Kenneth M Murphy and Theresa L Murphy, who have collaborated with her on various projects.
Conclusion
Michelle A Hurchla Pyles is a pioneering inventor whose work in lymphocyte modulation is paving the way for advancements in immunological therapies. Her contributions are vital to the ongoing research in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile